DAFTAR PUSTAKA Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. 2002. Molecular Biology of the Cell. Edisi ke-4. Garland Science: New York Alvarez, UG. 2012. Factors associated with late presentation of HIV and estimation of antiretroviral treatment need according to CD4 lymphocyte count in a resource-limited setting: data from an HIV cohort study in india. Interdiscip Perspect Infect Dis. Badri M, Lawn SD, Wood R. 2008. Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resourcelimited setting. BMC infectious diseases [Internet]. Jan [cited 2014 Mar 14];8(1):89. Available from: http://www.biomedcentral.com/ 14712334/8/89. Bonnet, F, Thiebaut R, Chene G, Neau D, Pellegrin JL, dan Mercie P. 2005. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France. 1996-2002. HIV Med. 6(3):198-205. Boris, J, Danielle P, Musie G, Carmen C, Marcus A, Henry S, Richard AM, and Bruce DW. 2012. Factors predicting discordant virological and immunological responses to antiretroviral therapy in HIV-1 clade C infected Zulu/Xhosa in South Africa. PLOS ONE 7:31161. Burnet Indonesia (Mac Farlane Burnet Institute for Medical Research and Public Health Limited). 2005. Buku Pegangan Konselor HIV, edisi 2. Diunduh dari www.burnet.internationalhealth.edu.au Crowe, Suzanne M., dkk. 1991. Predictive value of CD4 lymphocyte numbers for the develompment of opportunistic infection and malignances in HIVinfected person, Journal of Acquired Immuno Deficiency Syndrom. 4:770776. New York : Raven Press Ltd. De Maat,Monique, dkk. 2003. Drug interactions between antiretroviral drugs and comedicated agents. Clinic Pharmacokinetic. 42 (3), 23-262. Aclts International united. Departemen Kesehatan Republik Indonesia. 2004. Pedoman Nasional Terapi Antiretroviral. Jakarta. Departemen Kesehatan Republik Indonesia. Departemen Kesehatan RI. 2006. Pedoman pelayanan Kefarmasian Untuk Orang Dengan HIV/AIDS. Jakarta. Departemen Kesehatan Republik Indonesia. Departemen Kesehatan RI. 2007. Pedoman Nasional Terapi Antiretroviral. Edisi kedua. Jakarta. Departemen Kesehatan Republik Indonesia. 1
Diego, LC, Kristien V, Larissa O, David I, Juan E, Lynen L, Eduardo G, and Carlos S. 2008. Predictors of CD4+ cell count response and of adverse outcome among HIV-infected patients receiving highly active antiretroviral therapy in a public hospital in Peru. International Journal of Infectious Diseases 12: 325-331. Dipiro, J.T. 2005. Pharmacotherapy. A Pathophysiologic approach. Sixth Edition. USA: McGraw-Hill Companies Inc. Ditjen PPM&PL Depkes RI. 2009. Statistik kasus HIV di Indonesia, dilaporkan s/d Desember 2014. Jakarta. Departemen Kesehatan Republik Indonesia. Dore, Gregory dan Sasadeusz, Joe. 2006. Koinfeksi HIV dan Hepatitis Virus. Australia. Australasian society for HIV Medicine Inc. Evan W, Robert SH, Benita Y, Richard H,Michael VOS. 2004. The impact of adherence on CD4 cell count responses among HIV-infected patients. Journal of acquired immune deficiency syndromes [Internet]. [cited 2014 Mar 16];35:261–8. Available from:http://journals.lww.com/jaids/ Abstract/2004/03010/The_Impact_of_Adherence_on_CD4_Cell_Count.6.as Evering MD,Teresa H., & Markowitz Md,Martin. (2008). HIV-1 integrasse inhibitor. from The PRN notebook. New York. Vol.13. Physicians’Research Network. Fletcher, C., Kakuda, T.2002. HIV infection. In: Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., Posey, L.M. (Eds), Pharmacoterapy a Patophysiological Approach, 5th ed, St Louis: McGraw-hill Companies, Inc, p. 2151-2171. Fredy, Felix C, Frans Liwang, Rudy Kurniawan, Anna Uyainah ZN. 2012. The corelation between CD4+ t-lymphocyte count and tuberculosis form in TBHIV coinfected patients in Indonesia. The Indonesian Journal of Internal Medicine. 44: 122-127. Bartlet JG, Gallant JT, 2006, Medical Management of HIV Infections, John Hopkins University School of Medicine, Australia. Gandhi, RT, John S, Ellen C, David MA, Benigno R, Thomas C.M, Martin SH, Robert WS, Gregory KR, Richard BP, and the ACTG 384 Team. 2006. Effect of baseline and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-positive subjects: results from ACTG 384. Journal of Acquired Immune Deficiency Syndromes 42:426-434. Garcia, F, Elisa D Lazzari, Montserrat P, Pedro C, Gabriel M, Meritxell N, Emilio F, Esteban M, Josep M, Jose L Blanco, Jose M Miro, Tomas P, Teresa G, 2
dan Jose M Gatell. 2000. Long-term CD4+ t-cell response to highly active antiretroviral therapy according to baseline CD4+ t-cell count. Journal of Acquired Immune Deficiency Syndromes 36(2) :702-713. Gayle, HD and GL Hill. 2001. Global Impact Of Human Immunodeficiency Virus And AIDS. Clinical Epidemiology Reviews. 14 (2): 327-335. Ghate, MV. 2000. Relationship between clinical conditions and cd4 counts in hivinfected persons in Pune, Maharashtra, India. Natl Med J India. JulAug;13(4):183-7. Greenbaum, Adena H., dkk. 2008. Effect of age and HAART Regimen on clinical respon in an Urban cohort of HIV infected individual. AIDS NIH Public Access Author Manuscript. 12:22 (17). Guatellli, J.C., Siliciano, R.F., Kuritzkes, D.R., Richman, D.D., 2002. HIV. In:Richman, D.D., Whitley, R.J., Hayden, F.G. (Eds), Clinical Virology, 2nd ed, Washinton: ASM PRESS, P.685-703. Hoffmann, C., Rockstroh, J.K., Kamps B. S., 2006. HIV Medicine 2006, Paris: Flying Publiser Hoy, Jenifer, Sharon Lewin, Jeffrey JP, Alan Street. 2009. Managing The Patient On Antiretroviral Therapy. In: Vujovic, O. and Anna P HIV Management in Australia a Guide For Clinical Care. ed. Australia: Australasian Society for HIV Medicine Inc, pp. 93-101. Hughes R., Sabin C. dan Steem J. 2007. Long-term trend in CD4 count in patients HAART: UK-CHIC Study. Madrid 11th European AIDS Conference. Hutton B, Mills E, Angel J, Cooper C. Angel J. 2006. CD4 T lymphocyte recovery with antiretroviral therapy in HIV-HCV coinfection. JAC 62:7329. Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, et al. 2009. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America Jawetz, Melnick dan Adelberg. 2008. Medical Microbiology. Twenty Third Edition. USA: Mc. Graw-Hill Companies Inc. Judarwanto, Widodo. 2009. Faktor Resiko Gangguan Perkembangan Bicara dan Bahasa pada Anak Kassa, Desta, Leonie Ran, Wudneh Weldemeskel, Mekashaw Tebeje, Amelewerk Alemu, Yodit Alemayehu, et al. 2012. Clinical, hemato-immunological characteristics of mycobacterium tuberculosis patients with and without 3
HIV-1 infection: responses to six month tuberculosis treatment. Biomedicine International 3: 22-33. Katzung, Bertram G. 2001. Basic and Clinical Pharmacology. Eight Edition. USA : Mc. Graw-Hill Companies Inc Kaufmann, GR, Hansjakob F, Bruno L, Luc P, Milos O, Pietro V, et al. 2005. Characteristics, determinants, and clinical relevance of CD4 t cell recovery to >500 cells/ml in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clinical Infectious Diseases (CID) 41: 361–372. Kementrian Kesehatan RI. 2013. Statistik Kasus HIV/AIDS di Indonesia Dilapors/d Desember2013. Direktorat Jenderal Pengendalian Penyakit Dan Penyehatan Lingkungan. Jakarta. Kementerian Kesehatan RI. 2012. Petunjuk teknis tata laksana klinis ko-infeksi TB-HIV. Direktorat Jenderal Pengendalian Penyakit Dan Penyehatan Lingkungan. Jakarta. Kementrian Kesehatan RI. 2011. Pedoman Nasional Tatalaksana Klinis dan Infeksi HIV dan Terapi Antiretoviral Pada Orang Dewasa. Direktorat Jenderal Pengendalian Penyakit Dan Penyehatan Lingkungan. Jakarta. Laksana Agung Saprasetya Dwi dan Diyah Woro Dwi Lestari. 2010. Faktorfaktor risiko penularan HIV/AIDS pada laki-laki dengan orientasi seks heteroseksual dan homoseksual di Purwokerto. Mandala of Health.Volume 4, Nomor 2: 133-123. Lee, Anne. 2006. Adverse Drug Reaction. 2th Ed. Great Britain : Pharmaceutical Press. p.342. Liu, H, H. Yang, X Li, N Wang, H Liu, B.Wang, et al. 2005. Men who have sex with men and human immunodeficiency virus/sexually transmitted disease control in China. Cell Res 15 (11-12): 858–864. Mansjoer, A. 2001. Kapita selekta kedokteran. Edisi 3 Jakarta. Fakultas Kedokteran Universitas Indonesia. Jakarta. Mariam, S. 2010. Perbandingan respon imunologi empat kombinasi antiretroviral berdasarkan kenaikan jumlah CD4 di Rumah Sakit dr. H.Marzoeki Mahdi Bogor periode maret 2006-maret 2010. Universitas Indonesia. Jakarta. Mc Evoy, Gerald K. 2004. AHFS Drug Information. Amer Soc Health-System Pharmacists. Minzi,OMS. 2009. HIV patients presenting common adverse drug event caused by Highly Active Antiretroviral Therapy(HAART) in Tanzania. Tanzania Journal of Health Research. 11:1 4
Mulcahy, Stephen, 2005. The Toxicology of Cigarette Smoke and Environmental Tobacco Smoke. New York : Biochemical Toxicology Muzah, BP, S Takuva, M Maskew, and S Delany-Moretlwe. 2012. Risk factors for discordant immune response among HIV-infected patients initiating antiretroviral therapy: a retrospective cohort study. Southern African Journal of HIV Medicine 13(4). Nurbani, F. 2009. Dukungan sosial pada ODHA. Universitas Gunadarma. Jakarta. Nursalam. 2007. Asuhan keperawatan pada pasien terinfeksi HIV. Penerbit Salemba Medika. Jakarta. Nursalam. 2009. Model holistik berdasar teori adaptasi (roy dan pni) sebagai upaya modulasi respons imun (aplikasi pada pasien HIV & AIDS). Universitas Airlangga. Price, Sylvia A. & Wilson Lorraine M. 2008. Phathophysiology. Clinical Concepts of Disease processes. four edition. Mrsby Year Book. Inc. Raffi F Antiretroviral therapy -- new strategies or new drugs? 14th European AIDS Conference, Brussels, plenary PL6, 2013. Rahmadini, Yuliani. 2006. Perbandingan kenaikan jumlah CD4 rata-rata beberapa kombinasi antiretroviral pada pasien HIV/AIDS. Analisis data rekam medik RS kanker Darmais Jakarta. Depok : Farmasi UI. Radji, M. 2010. Imunologi dan virologi. PT. ISFI Penerbitan. Jakarta. Rasmun. 2004. Stres, koping, dan adaptasi. Jakarta: Agung Seto. Read, Jenifer S. dan Committe on Pediatric AIDS. 2007. Pediatrics. Diagnosis of HIV-infected in children younger than 18 month in the United State. USA: American Academy of Pediatrics. Richman DD. dkk. 1987, Juli 23. The toxicity of azidothymidine (AZT) in the treatment of patient with AIDS and AIDS-related complex. Nederland English Journal Medicine. 317 (4), 192 Robbins GK., Daniels B. dan Zheng H. 2000. Predictors of Antiretroviral Treatment Failure in an Urban HIV Clinic. J.Acquir. Immune. Defic.Syndrom. 44(1). 30-37. Smith CJ, Caroline A Sabin, Mike S Youle, Sabine K, Fiona C Lampe, S Madge, et al. 2004. Factors influencing increases in CD4 cell counts of HIVpositive persons receiving long-term highly active antiretroviral therapy. The Journal of Infectious Diseases 190: 1860- 1868. 5
Stockley, I.H. 2008. Stockley’s Drug Interaction. Edisi kedelapan. Great Britain Pharmaceutical Press. Tsibris MD, Athe. 2007. Update on CCR5 inhibitor: Scientific rationale clinical evidence and anticipated uses. New York: from The PRN notebook.Vol.12. Physicians’Research Network. UNAIDS. 2013. Case Report United Nations Programme on HIV/AIDS. Available from: http://www.unaids.org. 12 Februari 2014. (19:00). Van Lelyveld SFL, Gras L, Kesselring A, Zhang S, De Wolf F, Wensing AMJ, et al. 2012. Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch Athena cohort. AIDS London, England [Internet]. [cited 2013 Oct 2];26(4):465–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22112603. Viard, JP, Amanda M, Antonio C, Ole K, Birgit R, George P, Norbert V. 2001. Influence of age on CD4 cell recovery in human immunodeficiency virus– infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. The Journal of Infectious Diseases 183:1290– 4:1290-1294. WHO. 2004. Division of aids table for grading the severity of adult and pediatric adverse events 2004; clarification august 2009.Version 1.0. Available from :http://rsc.techres.com/Document/safetyandpharmacovigilance/Table_for Grading_Severity_of_Adult_Pediatric_Adverse_Events.pdf. WHO. 2008. Guideline Antiretroviral Therapy For Hiv Infection In Adults And Adolescents. WHO. WHO. 2009. Rapid advice: Antiretroviral therapy for HIV infection in adults and adolescents WHO. 2010. Antiretroviral therapy for HIV infection in adults and adolescents Recommendations for a public health approach 2010 revision. Available from: http://www.who.int/hiv/pub/arv/adult2010/en/. 13 Mei 2014 (17:00). WHO. 2014 Supplement Guidelines On The Use Of Antiretroviral Drugs For Treating And Preventing HIV Infection. Wibowo, Candra. 2002. Penatalaksanaan Baku Dan Menyeluruh Pada HIV/AIDS. dalam Cermin Dunia Kedokteran. No. 135 tahun 2002. Wolbers, M, Munuel B, Bernard H, Hansjakob F, Matthias C, Barbara H et al. 2007. CD4+ t-cell increase in HIV-1 infected patient with suppressed viral load within 1 year after start of antiretroviral therapy. International Media Press 1359-6535(12): 889-897. 6
